World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
129
Citations
59334
World Ranking
429
National Ranking
274

Medicine

D-Index
129
Citations
59239
World Ranking
2607
National Ranking
1462

Research.com Recognitions

  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

Ari Melnick is affiliated with Cornell University in the United States. Their research spans the fields of biochemistry, genetics, molecular biology, and medicine, with significant contributions to molecular biology, immunology, oncology, pathology and forensic medicine, and hematology.

The scientific work of Ari Melnick focuses on multiple topics, including:

  • Lymphoma Diagnosis and Treatment
  • Epigenetics and DNA Methylation
  • CAR-T cell therapy research
  • Immune Cell Function and Interaction
  • Acute Myeloid Leukemia Research
  • Cancer-related gene regulation
  • Protein Degradation and Inhibitors

Melnick has been an active contributor to notable academic venues. Their publications frequently appear in:

  • Blood
  • Blood Cancer Discovery
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Cancer Cell
  • Hematological Oncology

Among their recent papers are:

  • The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee, 2022, Blood
  • Histone H1 loss drives lymphoma by disrupting 3D chromatin architecture, 2020, Nature
  • An Embryonic Diapause-like Adaptation with Suppressed Myc Activity Enables Tumor Treatment Persistence, 2021, Cancer Cell
  • The therapeutic landscape for cells engineered with chimeric antigen receptors, 2020, Nature Biotechnology
  • Chemotherapy Induces Senescence-Like Resilient Cells Capable of Initiating AML Recurrence, 2021, Cancer Discovery

Frequent collaborators in Melnick's research include:

  • Cem Meydan
  • Christopher E. Mason
  • Wendy Béguelin
  • Christopher R. Chin
  • Olivier Elemento

Melnick's contributions extend through topics related to immune cell interactions and therapeutic strategies, particularly in lymphoma and leukemia. They are recognized as a member of the Association of American Physicians.

Best Publications

  • Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation.

    Maria E. Figueroa;Omar Abdel-Wahab;Chao Lu;Patrick S. Ward

  • Prognostic relevance of integrated genetic profiling in acute myeloid leukemia

    Jay P. Patel;Mithat Gönen;Maria E. Figueroa;Hugo Fernandez

  • IDH mutation impairs histone demethylation and results in a block to cell differentiation

    Chao Lu;Patrick S. Ward;Patrick S. Ward;Gurpreet S. Kapoor;Dan Rohle;Dan Rohle

  • methylKit: a comprehensive R package for the analysis of genome-wide DNA methylation profiles

    Altuna Akalin;Matthias Kormaksson;Sheng Li;Francine E Garrett-Bakelman

  • Deconstructing a Disease: RAR, Its Fusion Partners, and Their Roles in the Pathogenesis of Acute Promyelocytic Leukemia

    Ari Melnick;Jonathan D. Licht

  • Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation.

    Kelly Moran-Crusio;Linsey Reavie;Alan Shih;Omar Abdel-Wahab

  • Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells

    Jose M. Polo;Susanna Liu;Maria Eugenia Figueroa;Warakorn Kulalert

  • The NASA Twins Study: A multidimensional analysis of a year-long human spaceflight.

    Francine E. Garrett-Bakelman;Francine E. Garrett-Bakelman;Manjula Darshi;Stefan J. Green;Ruben C. Gur

  • The N 6 -methyladenosine (m 6 A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells

    Ly P Vu;Brian F Pickering;Yuanming Cheng;Sara Zaccara

  • DNA Methylation Signatures Identify Biologically Distinct Subtypes in Acute Myeloid Leukemia

    Maria E. Figueroa;Sanne Lugthart;Yushan Li;Claudia Erpelinck-Verschueren

  • A Molecular Roadmap of Reprogramming Somatic Cells into iPS Cells

    Jose M. Polo;Endre Anderssen;Endre Anderssen;Ryan M. Walsh;Benjamin A. Schwarz

  • EZH2 Is Required for Germinal Center Formation and Somatic EZH2 Mutations Promote Lymphoid Transformation

    Wendy Béguelin;Relja Popovic;Matt Teater;Yanwen Jiang

  • Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesis

    Lambert Busque;Jay P Patel;Maria E Figueroa;Aparna Vasanthakumar

  • ASXL1 mutations promote myeloid transformation through loss of PRC2-mediated gene repression.

    Omar Abdel-Wahab;Mazhar Adli;Lindsay M. LaFave;Jie Gao

  • IDH1(R132H) mutation increases murine haematopoietic progenitors and alters epigenetics

    Masato Sasaki;Christiane B. Knobbe;Christiane B. Knobbe;Joshua C. Munger;Evan F. Lind

  • DNMT1-interacting RNAs block gene-specific DNA methylation

    Annalisa Di Ruscio;Alexander K. Ebralidze;Touati Benoukraf;Giovanni Amabile

  • Comparative isoschizomer profiling of cytosine methylation: The HELP assay

    Batbayar Khulan;Reid F. Thompson;Kenny Ye;Melissa J. Fazzari

  • Outcome of Deferred Initial Therapy in Mantle-Cell Lymphoma

    Peter Martin;Amy Chadburn;Paul Christos;Karen Weil

  • The histone lysine methyltransferase KMT2D sustains a gene expression program that represses B cell lymphoma development.

    Ana Ortega-Molina;Isaac W. Boss;Andres Canela;Heng Pan

  • Distinct evolution and dynamics of epigenetic and genetic heterogeneity in acute myeloid leukemia

    Sheng Li;Francine E Garrett-Bakelman;Stephen S Chung;Mathijs A Sanders

Frequent Co-Authors

Ross L. Levine
Ross L. Levine Memorial Sloan Kettering Cancer Center
Maria E. Figueroa
Maria E. Figueroa University of Miami
Olivier Elemento
Olivier Elemento Cornell University
Markus Müschen
Markus Müschen Yale University
Christopher E. Mason
Christopher E. Mason Cornell University
Jonathan D. Licht
Jonathan D. Licht University of Florida
John M. Greally
John M. Greally Albert Einstein College of Medicine
Omar Abdel-Wahab
Omar Abdel-Wahab Memorial Sloan Kettering Cancer Center
Jose M. Polo
Jose M. Polo Monash University
Randy D. Gascoyne
Randy D. Gascoyne BC Cancer Agency

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Ari Melnick

Trending Scientists

Recently Published Articles